Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Frankfurt - Delayed Quote EUR

Balchem Corporation (BL9B.F)

Compare
141.70
-1.40
(-0.98%)
At close: April 4 at 4:18:18 PM GMT+2

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Theodore Lee Harris CEO, President & Chairman 2.19M -- 1965
Mr. Carl Martin Bengtsson Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health 803.56k -- 1978
Ms. Hatsuki Miyata J.D. Executive VP, Chief Legal Officer & Secretary 626.11k -- 1976
Mr. Martin Luther Reid Senior VP & Chief Supply Chain Officer 637.59k -- 1968
Mr. Frederic Boned Senior VP and GM of Human Nutrition & Health 644.93k -- 1979
Mr. William A. Backus CPA VP & Chief Accounting Officer 507.83k 956.51k 1966
Mr. Michael R. Sestrick Ph.D. Senior VP & CTO -- -- 1964
Mr. Jonathan H. Griffin Senior Vice President of Corporate Development 565.08k -- 1976
Mr. M. Brent Tignor Senior VP & Chief Human Resources Officer -- -- 1978
Mr. Job L. van Gunsteren Senior VP & GM of Specialty Products -- -- 1976

Balchem Corporation

5 Paragon Drive
Montvale, NJ 07645
United States
845 326 5600 https://www.balchem.com
Full Time Employees: 
1,361

Description

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Corporate Governance

Balchem Corporation’s ISS Governance QualityScore as of April 1, 2025 is 4. The pillar scores are Audit: 2; Board: 4; Shareholder Rights: 7; Compensation: 3.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 1, 2025 at 12:30 PM UTC - May 5, 2025 at 12:30 PM UTC

Balchem Corporation Earnings Date

Recent Events

December 27, 2024 at 12:00 AM UTC

Ex-Dividend Date